Gelesis

Gelesis is a pharmaceutical company developing treatments for overweight and obese patients struggling with impaired-fasting glucose and diabetes. It is based in Boston, Massachusetts. The Gelesis executive and advisory team includes some of the world's leading experts in obesity, materials science, chronic disease research, and commercialization. Gelesis was co-founded by PureTech Health (LSE: PRTC), a clinical-stage biotechnology company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases.